Best Biotech Stocks Right Now: Growth Leaders to Watch
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesBiotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
Global gun-control moves through the 1990s to today reshaped crime trends and investor risk. This piece examines outc...
Hyperliquid’s HIP-3 markets surged to $1.43 billion in open interest, driven by around-the-clock tokenized asset trad...
A new Stanford study finds tax refunds do little to blunt the impact of higher gasoline prices on American households...
Kalshi locks billion valuation as a $1B round led by Coatue pushes the U.S. prediction market leader to a $22B valuat...
Aave DAO cleared a key milestone by backing a Request for Comment for V4 via a snapshot vote, even as governance shak...
Both ServiceNow and Salesforce fell roughly 5% on the latest trading session as AI licensing concerns rattled investo...
Investors are weighing whether HOOD deserves a place in a modern portfolio. This guide helps you gauge signals, risks...
Bitcoin is slipping into the weekend as macro pressures mount and a political cue looms. Traders watch critical suppo...
Binance unveils a regional communications push, introduces new perpetual contracts, and plans to drop select trading ...
Carrington Mortgage Services is set to acquire Valon Mortgage, adding roughly $197 billion in UPB to its servicing po...
A federal court clears a $71 million ETH transfer on Arbitrum to Aave, but North Korea-linked creditors retain legal ...